DR info

Clinical trials : 11 / Drugs : 23 - (DrugBank : 12) / Drug target genes : 9 - Drug target pathways : 35

Idiopathic dilated cardiomyopathy and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
57	Idiopathic dilated cardiomyopathy
46	Malignant rheumatoid arthritis
96	Crohn disease
113	Muscular dystrophy
6	Parkinson disease
17	Multiple system atrophy
85	Idiopathic interstitial pneumonia
86	Pulmonary arterial hypertension
210	Single Ventricle
67	Polycystic kidney disease
11	Myasthenia gravis
58	Hypertrophic cardiomyopathy
2	Amyotrophic lateral sclerosis
169	Menkes disease
170	Occipital horn syndrome
22	Moyamoya disease
5	Progressive supranuclear palsy
28	Systemic amyloidosis
70	Spinal stenosis
118	Myelomeningocele
167	Marfan syndrome
127	Frontotemporal lobar degeneration
13	Multiple sclerosis/Neuromyelitis optica
280	Huge arteriovenous malformation with cervicofacial or limb lesion
215	Tetralogy of Fallot
288	Autoimmune acquired coagulation factor deficiency
66	IgA nephropathy
296	Biliary atresia
206	Fragile X syndrome
19	Lysosomal storage disease
8	Huntington disease
157	Sturge-Weber syndrome
278	Huge lymphatic malformation with cervicofacial lesion
49	Systemic lupus erythematosus
97	Ulcerative colitis
111	Congenital myopathy